Telix Appoints Paul Schaffer as Chief Technology Officer
MELBOURNE, Australia and INDIANAPOLIS, April 7, 2025 /PRNewswire/ -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, Telix, the Company) today announces that is has appointed Dr. Paul Schaffer to the newly created role of Chief Technology Officer (CTO), effective today. Dr. Schaffer has been CTO at ARTMS Inc. (ARTMS) (acquired by...
The Phase III Study Data of Stapokibart for Seasonal Allergic Rhinitis Published in Nature Medicine
CHENGDU, China, April 6, 2025 /PRNewswire/ -- Keymed Biosciences Inc. (HKEX: 02162) ("Keymed" or the "Company") today announced that the prestigious medical journal Nature Medicine has published the results from the Phase III trial of its independently developed IL-4Rα antibody stapokibart, for the treatment of moderate-to-severe seasonal allergic rhinitis (SAR). The study, led by Professor Luo Zhang of Beijing Tongren Hospital,...
Breakthrough Prize Foundation Announces Student Winner of 10th Annual Breakthrough Junior Challenge Science Video Competition
Jasmine Eyal, Age 16, of Singapore, Receives Top Honors and $400,000 in Education Prizes for her Original Video Explaining Mechanogenetic Cellular Engineering LOS ANGELES, April 6, 2025 /PRNewswire/ -- The Breakthrough Prize Foundation today announced Singapore-based Jasmine Eyal as winner of the 10th annual Breakthrough Junior Challenge, a global science video competition...
BREAKTHROUGH PRIZE ANNOUNCES 2025 LAUREATES IN LIFE SCIENCES, FUNDAMENTAL PHYSICS, AND MATHEMATICS
"Oscars® of Science" Awards Six $3 Million Prizes GLP-1 Diabetes and Obesity Discovery | Multiple Sclerosis Causes and Treatments | DNA Editing Exploration of Nature at Shortest Distances Proof of Geometric Langlands Conjecture Special Prize Awarded to Giant of Theoretical Physics Breakthrough Prize in Life Sciences Awarded to Daniel J. Drucker, Joel Habener,...
I Peace Launches Personalized iPS Cell Services and Longevity Treatment in the U.S.
– Age-Reversed Stem Cell Technology Now Available to the Public – PALO ALTO, Calif., April 5, 2025 /PRNewswire/ -- I Peace, Inc. (https://ipeace.com/en/), a global pioneer in iPSC (induced pluripotent stem cell) technology, proudly announces the launch of its personalized iPS cell production and longevity-focused rejuvenation therapies in the United States....
ITRI Wins Seven 2025 Edison Awards for Groundbreaking Technologies
FORT MYERS, Fla., April 5, 2025 /PRNewswire/ -- The Industrial Technology Research Institute (ITRI) secured an impressive seven awards at the 2025 Edison Awards™ with its cutting-edge technological innovations. Out of 140 winners, ITRI garnered three golds, three silvers, and one bronze, holding the highest total by an Asia-based organization this year....
Ex-FDA Expert Dr. Yaning Wang Joins Tsingke to Drive Small Nucleic Acid Drug Innovation
BEIJING, April 4, 2025 /PRNewswire/ -- Recently, Beijing Tsingke Biotech Co., Ltd. officially announced the appointment of Dr. Yaning Wang, a former senior expert at the FDA, as the company's Chief Scientific Advisor in the field of small nucleic acid. This collaboration injects strong momentum into Tsingke's growth in small nucleic acid drugs raw materials, marking a significant enhancement in...
NUS researchers combine 3D bioprinting with AI to personalise oral soft tissue grafts
Artificial intelligence streamlines the optimisation of bioprinting parameters for oral soft tissue grafts, reducing time and resource demands while enabling efficient, personalised dental treatments SINGAPORE, April 4, 2025 /PRNewswire/ -- A team of researchers from the National University of Singapore (NUS) has developed a method to fabricate personalised gingival (gum) tissue grafts using an innovative combination of 3D bioprinting...
OSR Holdings, Inc. (NASDAQ: OSRH) Enters Into $80 Million Common Stock Purchase Agreement With White Lion GBM Innovation Fund, With An Eye Towards Leveraging Innovate GBM’s Non-Profit Ecosystem to...
SEOUL, South Korea, April 3, 2025 /PRNewswire/ -- OSR Holdings, Inc. ("OSR") (NASDAQ: OSRH), a global healthcare company focused on advancing innovative therapies, today announced that it has entered into a Common Stock Purchase Agreement with White Lion GBM Innovation Fund ("Innovation Fund"). Under this agreement, OSR has the right, but not...
Farrer Park Hospital and Alliance Healthcare Group Limited Forge Strategic Partnership to Enhance Patient Care and Promote Sustainable Healthcare Models
SINGAPORE, April 3, 2025 /PRNewswire/ -- Farrer Park Hospital and Alliance Healthcare Group Limited (Alliance) had on 27 March 2025 entered into a strategic partnership to drive innovation in healthcare delivery, strengthen collaboration between providers, payers, and physicians, and improve patient outcomes. The partnership will focus on developing a sustainable model for...
